As of May 2022 Onconova Therapeutics has a market cap of $0.02 Billion. This makes Onconova Therapeutics the world's 6152th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $0.02 B | -57.24% |
2021 | $0.05 B | -38.16% |
2020 | $0.08 B | 102.34% |
2019 | $0.04 B | 255.62% |
2018 | $0.01 B | -25.9% |
2017 | $0.01 B | 5.29% |
2016 | $0.01 B | -37.02% |
2015 | $0.02 B | -65.88% |
2014 | $0.07 B | -71.03% |
2013 | $0.24 B |
On May 24th, 2022 the market cap of Onconova Therapeutics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Baxter BAX | $37.21 B | 164,788.48% | ๐บ๐ธ USA |
![]() Spectrum Pharmaceuticals
SPPI | $0.12 B | 466.26% | ๐บ๐ธ USA |
![]() CTI BioPharma
CTIC | $0.56 B | 2,396.36% | ๐บ๐ธ USA |
![]() Cleveland BioLabs
CBLI | $0.04 B | 117.43% | ๐บ๐ธ USA |
![]() Array Technologies ARRY | $1.38 B | 6,035.50% | ๐บ๐ธ USA |